GGrantIndex
Sort

16,179 grants matching malaria

Immunopathogenesis of Severe Malaria During Pregnancy

$300,434
Julie M Moore · University Of Georgia · R01 · FY2015 · HD

REGULATION OF ENERGY METABOLISM IN MOSQUITOES

$300,425
University Of Arizona · R01 · FY2004 · AI

REGULATION OF ENERGY METABOLISM IN MOSQUITOES

$300,425
University Of Arizona · R01 · FY2003 · AI

REGULATION OF ENERGY METABOLISM IN MOSQUITOES

$300,425
University Of Arizona · R01 · FY2005 · AI

Scanning the P. falciparum proteome for vaccine antigens

$300,389
Philip Louis Felgner · Immport Therapeutics, Inc. · R43 · FY2006 · AI

Repurposing pyronaridine as a treatment for Chagas disease

$300,277
Sean Ekins · Collaborations Pharmaceuticals, Inc. · UH2 · FY2018 · TR

Specificity in Terpene and Sterol Biosynthesis

$300,264
University Of Illinois Urbana-Champaign · R01 · FY2005 · GM

Molecular Ecology of Neotropical Anophelines in the Peruvian and Brazilian Amazon

$300,155
Jan E. Conn · University Of California, San Diego · U19 · FY2012 · AI

Expression of Exogenous Genes in Vector Mosquitoes

$300,096
University Of California Irvine · R01 · FY2002 · AI

CLONING OF PLASMODIUM REFRACTORINESS GENES IN A GAMBIAE

$300,088
University Of Notre Dame · R01 · FY2003 · AI

Population Biology of African Malaria Vectors and Parasites

$300,080
Guiyun Yan · University Of California-Irvine · D43 · FY2020 · TW

Expression of Exogenous Genes in Vector Mosquitoes

$300,028
University Of California Irvine · R01 · FY2003 · AI

Bacterial Division and the Dynamics of the Z-ring

$300,013
Johns Hopkins University · R01 · FY2005 · GM

Improving Production of Attenuated Malaria Sporozoite Vaccines through Genetic Mo

$300,000
Peter F. Billingsley · Sanaria, Inc. · R43 · FY2008 · AI

Vaccination with purified, cryopreserved, infectious Plasmodium vivax sporozoites

$300,000
Stephen Lev Hoffman · Sanaria, Inc. · R43 · FY2012 · AI

Adenovirus Vectors for Respiratory Syncytial Virus Vaccination

$300,000
Jason Graham Gall · Genvec, Inc. · R43 · FY2008 · AI

Antibodies to malaria blood stages in mixed-species infections

$300,000
Xiaowu Liang · Immport Therapeutics, Inc. · R43 · FY2008 · AI

A New HBV Drug For Establishing Durable Antiviral Efficacy of HBV Treatment

$300,000
Yong-Yuan Zhang · Hbvtech · R43 · FY2021 · AI

Potency of cryopreserved, irradiated sporozoite vaccine

$300,000
Sanaria, Inc. · R43 · FY2004 · AI

In vitro bioreactor production of a genetically modified late liver stage-arresting replication competent Plasmodium falciparum sporozoite vaccine

$300,000
B. Kim Lee Sim · Sanaria, Inc. · R43 · FY2023 · AI

Collaborative Research: Production of known and novel, safe, and biodegradable pyrethrin-type insecticides in tomato

$300,000
Robert L Last · Michigan State University · · FY2016 · ENG

Quantum Dot-based Qualitative and Quantitative Multiplex Strip Test for Malaria I

$300,000
Y Andrew Wang · Ocean Nanotech, Llc · R43 · FY2011 · AI

3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target

$300,000
Virginia Commonwealth University · R01 · FY2004 · AI

Automated target concentration, signal enhancement, and detection in a single point-of-care paper-based diagnostic

$300,000
Daniel T Kamei · University Of California-Los Angeles · · FY2017 · ENG

ARF6 Inhibitor as Adjunctive Therapy for Treatment of SA Bacteremia

$300,000
Alan L Mueller · Navigen, Inc. · R43 · FY2018 · AI